These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
989 related articles for article (PubMed ID: 3263867)
1. Effects of muroctasin on the activities of drug metabolizing enzymes in liver microsomes of rats. Kamataki T; Komori M; Iwasaki M; Ohi H; Kitada M; Miura T; Ono K Arzneimittelforschung; 1988 Jul; 38(7A):1019-22. PubMed ID: 3263867 [TBL] [Abstract][Full Text] [Related]
2. [Effect of benzodiazepines on drug-metabolizing enzymes. II. Increased environmental temperature as a modifier of the effect of nitrazepam on microsomal monooxygenases of the rat liver]. Pachecka J; Kobylińska K; Brozyna M; Bicz W Acta Pol Pharm; 1988; 45(3):271-5. PubMed ID: 3239430 [No Abstract] [Full Text] [Related]
3. Zinc mediates normalization of hepatic drug metabolizing enzymes in chlorpyrifos-induced toxicity. Goel A; Dani V; Dhawan DK Toxicol Lett; 2007 Feb; 169(1):26-33. PubMed ID: 17194553 [TBL] [Abstract][Full Text] [Related]
4. Hepatic microsomal mixed-function oxidases in rats exposed to high ambient temperature. Pachecka J; Kobylińska K; Miaskiewicz H; Bicz W Acta Physiol Pol; 1983; 34(5-6):563-8. PubMed ID: 6679992 [TBL] [Abstract][Full Text] [Related]
5. Role of 3,4-dichlorophenyl methyl sulfone, a metabolite of o-dichlorobenzene, in the changes in hepatic microsomal drug-metabolizing enzymes caused by o-dichlorobenzene administration in rats. Kato Y; Kimura R Toxicol Appl Pharmacol; 1997 Aug; 145(2):277-84. PubMed ID: 9266800 [TBL] [Abstract][Full Text] [Related]
6. The effect of certain vitamin deficiencies on hepatic drug metabolism. Zannoni VG; Sato PH Fed Proc; 1976 Nov; 35(13):2464-9. PubMed ID: 976490 [TBL] [Abstract][Full Text] [Related]
7. Concurrent subacute exposure to arsenic through drinking water and malathion via diet in male rats: effects on hepatic drug-metabolizing enzymes. Naraharisetti SB; Aggarwal M; Sarkar SN; Malik JK Arch Toxicol; 2008 Aug; 82(8):543-51. PubMed ID: 18528686 [TBL] [Abstract][Full Text] [Related]
8. General pharmacological properties of muroctasin. Kojima H; Hirohashi M; Kasai Y; Takasuna K; Fukumoto C; Akashi A Arzneimittelforschung; 1988 Jul; 38(7A):1002-9. PubMed ID: 3190791 [TBL] [Abstract][Full Text] [Related]
9. [State of the microsomal oxidative system of the rat liver in acute intestinal obstruction]. Krakovskiĭ ME; Ashirmetov AKh; Komarin AS; Faĭngol'd DIa Vopr Med Khim; 1988; 34(3):117-20. PubMed ID: 3420799 [TBL] [Abstract][Full Text] [Related]
10. Influence of dietary thiamin on phenobarbital induction of rat hepatic enzymes responsible for metabolizing drugs and carcinogens. Wade AE; Evans JS; Holmes D; Baker MT Drug Nutr Interact; 1983; 2(2):117-30. PubMed ID: 6432511 [TBL] [Abstract][Full Text] [Related]
11. Effect of repeated administration of monomethyl-aminoantipyrine on the activities of gamma-glutamyltranspeptidase and microsomal drug metabolizing enzymes in rat liver. Hoshi K; Senda N; Igarashi T; Satoh T; Ueno K; Kitagawa H Res Commun Chem Pathol Pharmacol; 1985 Jun; 48(3):431-43. PubMed ID: 2862671 [TBL] [Abstract][Full Text] [Related]
12. [Effect of thiamine on the activity of liver endoplasmic reticulum enzymes metabolizing drugs]. Sushko LI; Lukienko PI Farmakol Toksikol; 1979; 42(1):56-9. PubMed ID: 421893 [TBL] [Abstract][Full Text] [Related]
13. Hepatic mixed-function oxidase system and microsomal lipid peroxidation in rats treated with a synthetic immunomodulator, N-acetylmuramyl-L-alanyl-D-isoglutamine (MDP). Yanev S; Zídek Z; Kadiiska M; Serbinova E; Masek K; Stoytchev T Methods Find Exp Clin Pharmacol; 1984 Jun; 6(6):311-5. PubMed ID: 6748821 [TBL] [Abstract][Full Text] [Related]
14. Local tolerance of muroctasin injection in rabbits. Nakashima K; Jindo T; Nomura M Arzneimittelforschung; 1988 Jul; 38(7A):1038-9. PubMed ID: 3190798 [TBL] [Abstract][Full Text] [Related]
15. Effect of "drugs for liver disease" on hepatotoxic action of carbon tetrachloride. II. Effect of protoporphyrin and phosphorylcholine on microsomal drug-metabolizing enzyme activities and the components in injuried liver. Ogiso T; Kobayashi T; Kuhara K; Kato Y Jpn J Pharmacol; 1975 Aug; 25(4):411-21. PubMed ID: 813044 [TBL] [Abstract][Full Text] [Related]
16. [Studies on correlation between liver drug metabolizing enzyme activities and microsomal membrane fluidity in phenobarbital treated rats]. Fu LS; Peng RX Yao Xue Xue Bao; 1991; 26(8):567-71. PubMed ID: 1805518 [TBL] [Abstract][Full Text] [Related]
17. Effect of Schistosoma mansoni infection on the hepatic drug-metabolizing capacity of mice. Cha YN; Edwards R J Pharmacol Exp Ther; 1976 Nov; 199(2):432-40. PubMed ID: 185361 [TBL] [Abstract][Full Text] [Related]
18. Effect of nicotinamide administration to rats on the liver microsomal drug metabolizing enzymes. Nomura K; Shin M; Sano K; Umezawa C; Shimada T Int J Vitam Nutr Res; 1983; 53(1):36-43. PubMed ID: 6222007 [TBL] [Abstract][Full Text] [Related]
19. Effect of phenobarbital on the distribution of drug metabolizing enzymes between periportal and perivenous rat hepatocytes prepared by digitonin-collagenase liver perfusion. Bengtsson G; Julkunen A; Penttilä KE; Lindros KO J Pharmacol Exp Ther; 1987 Feb; 240(2):663-7. PubMed ID: 3027320 [TBL] [Abstract][Full Text] [Related]
20. Phase I study and clinical pharmacological study of muroctasin. Ichihara N; Kanazawa R; Sasaki S; Ono K; Otani T; Yamaguchi F; Une T Arzneimittelforschung; 1988 Jul; 38(7A):1043-69. PubMed ID: 3263868 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]